
Please try another search
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a risk stratification spatial-omics test to predict future development of progression of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide optimal drug treatment for patients diagnosed with major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. The company offers its products to skin cancer and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.
Name | Age | Since | Title |
---|---|---|---|
Derek J. Maetzold | 63 | 2007 | Founder, CEO, President & Director |
Kenneth D. Aldape | - | - | Member of Scientific Advisory Board |
Daniel Mark Bradbury | 64 | 2012 | Independent Chairman of the Board |
G. Bradley Cole | 69 | 2018 | Independent Director |
Rodney Cotton | 65 | 2024 | Independent Director |
Miles D. Harrison | 60 | 2020 | Independent Director |
Tiffany P. Olson | 66 | 2021 | Independent Director |
Kimberlee S. Caple | 63 | 2021 | Independent Director |
Ellen Goldberg | 51 | 2021 | Independent Director |
Howard Colman | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review